Rasmus Holm-Jorgensen
Chief Financial Officer · Acrivon Therapeutics, Inc.
Individual
- 2024
- Nov 27, 2024
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rasmus Holm-Jorgensen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Blume-Jensen - $117K in ACRV purchases and sales in the last 12 months
- Eric Devroe - $18K in ACRV purchases and sales in the last 12 months
- Adam D. Levy - $17K in ACRV purchases and sales in the last 12 months
- Mary Miller - $2K in ACRV purchases and sales in the last 12 months
- Erick Gamelin - $804 in ACRV purchases and sales in the last 12 months
- Katharine Peterson - $203 in ACRV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rasmus Holm-Jorgensen?
Rasmus Holm-Jorgensen is a corporate insider, tracked as Chief Financial Officer of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Rasmus Holm-Jorgensen last file a Form 4?
The most recent primary Form 4 on record is dated 27 November 2024, one of 2 filings going back to 2024.
